Immunotherapies for Breast Cancer - How Immune System and Cancer are associated and on what the Research works?

被引：0
作者：
Almstedt, Katrin [1 ]
Schmidt, Marcus [1 ]
机构：
[1] Johannes Gutenberg Univ Mainz, Univ Med, Klin & Poliklin Geburtshilfe & Frauenkrankheit, Abt Konservat & Mol Gynakol Onkol, Mainz, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2016年 / 76卷 / 05期
关键词：
TUMOR-INFILTRATING LYMPHOCYTES; PERTUZUMAB PLUS TRASTUZUMAB; NEOADJUVANT CHEMOTHERAPY; PD-L1; EXPRESSION; PROGNOSTIC VALUE; DOCETAXEL; THERAPY; SAFETY; WOMEN; TRIAL;
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：503 / 506
页数：4
相关论文
共 34 条
[1]   Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199 [J].
Adams, Sylvia ;
Gray, Robert J. ;
Demaria, Sandra ;
Goldstein, Lori ;
Perez, Edith A. ;
Shulman, Lawrence N. ;
Martino, Silvana ;
Wang, Molin ;
Jones, Vicky E. ;
Saphner, Thomas J. ;
Wolff, Antonio C. ;
Wood, William C. ;
Davidson, Nancy E. ;
Sledge, George W. ;
Sparano, Joseph A. ;
Badve, Sunil S. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :2959-+
[2]   Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer [J].
Baselga, Jose ;
Cortes, Javier ;
Kim, Sung-Bae ;
Im, Seock-Ah ;
Hegg, Roberto ;
Im, Young-Hyuck ;
Roman, Laslo ;
Pedrini, Jose Luiz ;
Pienkowski, Tadeusz ;
Knott, Adam ;
Clark, Emma ;
Benyunes, Mark C. ;
Ross, Graham ;
Swain, Sandra M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (02) :109-119
[3]   Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-Positive and Triple-Negative Primary Breast Cancers [J].
Denkert, Carsten ;
von Minckwitz, Gunter ;
Brase, Jan C. ;
Sinn, Bruno V. ;
Gade, Stephan ;
Kronenwett, Ralf ;
Pfitzner, Berit M. ;
Salat, Christoph ;
Loi, Sherene ;
Schmitt, Wolfgang D. ;
Schem, Christian ;
Fisch, Karin ;
Darb-Esfahani, Silvia ;
Mehta, Keyur ;
Sotiriou, Christos ;
Wienert, Stephan ;
Klare, Peter ;
Andre, Fabrice ;
Klauschen, Frederick ;
Blohmer, Jens-Uwe ;
Krappmann, Kristin ;
Schmidt, Marcus ;
Tesch, Hans ;
Kuemmel, Sherko ;
Sinn, Peter ;
Jackisch, Christian ;
Dietel, Manfred ;
Reimer, Toralf ;
Untch, Michael ;
Loibl, Sibylle .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (09) :983-991
[4]   Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer [J].
Denkert, Carsten ;
Loibl, Sibylle ;
Noske, Aurelia ;
Roller, Marc ;
Mueller, Berit Maria ;
Komor, Martina ;
Budczies, Jan ;
Darb-Esfahani, Silvia ;
Kronenwett, Ralf ;
Hanusch, Claus ;
von Toerne, Christian ;
Weichert, Wilko ;
Engels, Knut ;
Solbach, Christine ;
Schrader, Iris ;
Dietel, Manfred ;
von Minckwitz, Gunter .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) :105-113
[5]   HOST RESISTANCE IN RELATION TO SURVIVAL IN BREAST-CANCER [J].
DIPAOLA, M ;
ANGELINI, L ;
BERTOLOTTI, A ;
COLIZZA, S .
BMJ-BRITISH MEDICAL JOURNAL, 1974, 4 (5939) :268-270
[6]   Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer Type [J].
Gatalica, Zoran ;
Snyder, Carrie ;
Maney, Todd ;
Ghazalpour, Anatole ;
Holterman, Daniel A. ;
Xiao, Nianqing ;
Overberg, Peggy ;
Rose, Inga ;
Basu, Gargi D. ;
Vranic, Semir ;
Lynch, Henry T. ;
Von Hoff, Daniel D. ;
Hamid, Omid .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (12) :2965-2970
[7]   Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial [J].
Gianni, Luca ;
Pienkowski, Tadeusz ;
Im, Young-Hyuck ;
Roman, Laslo ;
Tseng, Ling-Ming ;
Liu, Mei-Ching ;
Lluch, Ana ;
Staroslawska, Elzbieta ;
de la Haba-Rodriguez, Juan ;
Im, Seock-Ah ;
Pedrini, Jose Luiz ;
Poirier, Brigitte ;
Morandi, Paolo ;
Semiglazov, Vladimir ;
Srimuninnimit, Vichien ;
Bianchi, Giulia ;
Szado, Tania ;
Ratnayake, Jayantha ;
Ross, Graham ;
Valagussa, Pinuccia .
LANCET ONCOLOGY, 2012, 13 (01) :25-32
[8]   Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 [J].
Goldhirsch, A. ;
Winer, E. P. ;
Coates, A. S. ;
Gelber, R. D. ;
Piccart-Gebhart, M. ;
Thuerlimann, B. ;
Senn, H. -J. .
ANNALS OF ONCOLOGY, 2013, 24 (09) :2206-2223
[9]   The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis [J].
Ibrahim, Ezzeldin M. ;
Al-Foheidi, Meteb E. ;
Al-Mansour, Mubarak M. ;
Kazkaz, Ghieth A. .
BREAST CANCER RESEARCH AND TREATMENT, 2014, 148 (03) :467-476
[10]   PD-1 and its ligands in tolerance and immunity [J].
Keir, Mary E. ;
Butte, Manish J. ;
Freeman, Gordon J. ;
Sharpel, Arlene H. .
ANNUAL REVIEW OF IMMUNOLOGY, 2008, 26 :677-704
1234